Sinopec pays $1.5 billion for Talisman North Sea stake
By Scott Haggett
CALGARY, Alberta (Reuters) - Talisman Energy Inc (TLM.TO: Quote) said on Monday that Sinopec Corp (600028.SS: Quote), China's top refiner, has agreed to buy a 49 percent stake in its North Sea operations for $1.5 billion as the Canadian company looks to strengthen a balance sheet battered by weak natural gas prices.
Talisman, Canada's No. 6 oil and gas exploration company, will form a joint venture with Sinopec to operate the assets, which produced 63,000 barrels of oil equivalent per day in the first quarter of 2012, about 14 percent of the company's total output.
Talisman has long looked to lower its stake in the North Sea, where it has had little exploration success and where higher taxes have lifted costs. Chief Executive John Manzoni has deployed cash generated in the region into Talisman's promising North American shale fields and its Southeast Asian oil fields.
"Talisman has delivered on two key promises for the year," Manzoni said in a statement.
"We are reducing our working interest and capital spend in the UK business by approximately half, allowing us to focus on and fund growth areas within our portfolio."
It was the second major investment in a Canadian oil explorer by a Chinese company announced on Monday, after CNOOC Ltd (0883.HK: Quote) agreed to buy Nexen Inc NXY.TO for $15.1 billion. That was China's largest offer for a foreign oil producer since U.S. regulators foiled an $18.5 billion bid for Unocal Corp in 2005.
Sinopec will take a 49 percent stake in Talisman's North Sea assets, which Talisman will operate. With a partner on board, Talisman said it will defer decommissioning of some platforms and look to do additional infill drilling and exploration.
Analysts said the new partnership will lower Talisman's exposure to the North Sea and could make its production forecasts more reliable. Operating issues with its UK platforms have in the past caused the company to come up short of expectations and disappoint investors and analysts. Continued...